HA
ABBV icon

Herold Advisors’s AbbVie ABBV Stock Holding History

Herold Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.63M Hold
35,090
– – 1.68% 11
2025
Q4 		$8.02M Sell
35,090
-757
-2% -$172K 1.79% 10
2025
Q3 		$8.3M Buy
35,847
+1,683
+5% +$343K 1.92% 6
2025
Q2 		$6.34M Sell
34,164
-1,802
-5% -$335K 1.33% 15
2025
Q1 		$7.54M Sell
35,966
-1,776
-5% -$345K 1.65% 9
2024
Q4 		$6.71M Sell
37,742
-1,002
-3% -$184K 1.46% 11
2024
Q3 		$7.65M Sell
38,744
-405
-1% -$75.6K 1.66% 7
2024
Q2 		$6.72M Buy
39,149
+804
+2% +$133K 1.55% 8
2024
Q1 		$6.98M Sell
38,345
-433
-1% -$74.6K 1.69% 8
2023
Q4 		$6.01M Buy
38,778
+682
+2% +$99.4K 1.66% 9
2023
Q3 		$5.68M Buy
38,096
+2,568
+7% +$377K 1.73% 9
2023
Q2 		$4.79M Buy
35,528
+1,558
+5% +$228K 1.47% 10
2023
Q1 		$5.41M Buy
33,970
+38
+0.1% +$5.81K 1.87% 8
2022
Q4 		$5.48M Buy
33,932
+1,534
+5% +$235K 2.32% 5
2022
Q3 		$4.35M Buy
32,398
+289
+0.9% +$41.5K 2.09% 5
2022
Q2 		$4.92M Buy
32,109
+264
+0.8% +$40.3K 2.19% 5
2022
Q1 		$5.16M Buy
31,845
+1,173
+4% +$170K 1.84% 6
2021
Q4 		$4.15M Sell
30,672
-141
-0.5% -$16.7K 1.61% 9
2021
Q3 		$3.32M Buy
+30,813
New +$3.52M 1.29% 8

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Herold Advisors's ABBV Position: Q1 2026 in Review

Herold Advisors held its AbbVie (ABBV) position steady in Q1 2026 at 35,090 shares worth $7.63M. The position accounts for 1.68% of the portfolio, ranked #11.

Herold Advisors first reported a position in ABBV in Q3 2021 and has held it in 19 quarters since. The position peaked at $8.3M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Herold Advisors held 35,090 shares of AbbVie worth $7.63M as of Q1 2026.
  • Herold Advisors left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 1.68% of Herold Advisors's portfolio in Q1 2026, its #11 holding.
  • Herold Advisors first reported a position in AbbVie in Q3 2021 and has held it in 19 quarters since.
  • Herold Advisors's AbbVie position peaked at $8.3M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Herold Advisors's 13F filing for Q1 2026, filed 15 May 2026.